Committee on Import Licensing - Agreement on import licensing procedures - Notification under article 5.1 to 5.4 of the Agreement - Ukraine

agreement on import licensing procedures

Notification under Article 5.1 to 5.4 of the Agreement[1]

Ukraine

The following communication, dated 16 April 2025, is being circulated at the request of the delegation of Ukraine.

 

 

Category

Notification details

1

Notifying Member

Ukraine

2

Title of new legislation/procedure

The Resolution of the Cabinet of Ministers of Ukraine No. 166 "On Amendments to Certain Resolutions of the Cabinet of Ministers of Ukraine on Parallel Imports of Medicines" of 14 February 2025

3

Date of Publication

25 February 2025

4

Date of entry into force

25 February 2025

5

Website link/Official publication of the new regulation/procedure

https://zakon.rada.gov.ua/laws/show/166-2025-%D0%BF#Text

6

Have you attached a copy of the regulation (PDF) to the Secretariat

[] Yes. (Please attach a copy of the regulation to the notification.)

 

[X] No.

7

Type of notification

[X] (a) New licensing regulation/procedure[2]; (please answer question 8 to 14)

 

[] (b) Changes to a regulation/procedure which has been previously notified in document: (please answer question 15 and 16)

8

List of products subject to licensing

30 (HS-22) Pharmaceutical Products

9

Nature of licensing

Automatic: []

 

Non-Automatic: [X]

10

Administrative purpose/measure being implemented

(a)

                             

Protect public morals;

(b)

                             

Protect human, animal or plant life and health; protect environment;

(c)

                             

Collect trade statistics or market surveillance;

(d)

                             

Protection of patents, trademarks and copyrights, and the prevention of deceptive practices;

(e)

                             

Pursue obligations under the UN Charter and other international treaties (i.e. CITES, Basel Convention, Rotterdam Convention, UNSC Resolutions etc.)

(f)

                             

Quota (including TRQ) administration;

(g)

                             

Regulate imports of arms, ammunition or fissionable materials and safeguard national security;

(h)

                             

Other: ______________ (please specify)

11

Administrative body(ies) for submission of applications

Ministry of Health of Ukraine

Address: 01601, Kyiv, vul. Hrushevskoho, 7

Website: https://moz.gov.ua/uk

Telephone: +38 044 253 61 94

Email: moz@moz.gov.ua

12

Contact point for information on eligibility

Ministry of Health of Ukraine

Address: 01601, Kyiv, vul. Hrushevskoho, 7

Website: https://moz.gov.ua/uk

Telephone: +38 044 253 61 94

Email: moz@moz.gov.ua

13

Expected duration of licensing procedure

Ongoing

14

A summary of the notification in one of the WTO official languages

The Resolution was adopted following the provisions of the Law of Ukraine of 16 July 2024 No. 3860 "On Amendments to Certain Laws of Ukraine Regarding Parallel Import of Medicines".

Clause 78 of the Law of Ukraine of 28 July 2022 No. 2469 "On Medicines" (as amended by the Law of Ukraine No. 3860), provides that the procedure for issuing, amending, suspending, cancelling or terminating the validity of a permit for parallel import of a medicine shall be approved by the central executive authority responsible for the formation and implementation of state policy in the field of healthcare.

Pursuant to the Resolution of the Cabinet of Ministers of Ukraine No. 166 of 14 February 2025, until the establishment of the central executive authority with special status responsible for implementing state policy in the field of development, market authorization, quality control, safety, and efficacy of medicines, as defined by the Law of Ukraine No. 2469 "On Medicines" of 28 July 2022:

- the State Service of Ukraine on Medicines and Drugs Control shall be responsible for making decisions on issuance or refusal to issue permits for parallel import of medicines, as well as for suspension, cancellation or termination of such permits, and for exercising other powers related to state supervision and control over medicines imported into Ukraine as parallel import, as prescribed by the Law;

- the State Enterprise "State Expert Centre of the Ministry of Health of Ukraine" shall consider applications and accompanying documents submitted by business entities for obtaining, cancelling or amending permits for parallel import of medicines.

15

In the case of 7(b), please indicate the type of new change(s)

(a)

                             

Termination

(b)

                             

Suspension

(c)

                             

Modification of specific details in existing

procedures:

                             

Product coverage;

                             

Administrative purpose;

                             

Automatic or Non-automatic;

                             

Duration of licensing;

                             

Change the nature of quantity/value restriction;

                             

Eligibility of applicants;

                             

Contact information on eligibility;

                             

Administrative body(ies) for submission of application;

                             

Documentation requirements (including application form);

                             

Period for Application;

                             

Administrative body(ies) to issue licence;

                             

Processing time for issuing licence;

                             

Licence fee/administrative charge;

                             

Deposit/advance payment and relevant conditions;

                             

Appeal regulations/procedures;

                             

Validity of licence;

                             

Other conditions of licence (extension, transferability, penalty of non-use etc.);

                             

Foreign exchange requirements;

                             

Other:

16

Please elaborate the changes in detail (in one of the WTO official languages)

 

__________



[1] It is understood that the notifying Member has also completed its notification obligations under Article 1.4(a) and Article 8.2(b) regarding the relevant law/regulation/procedure notified for by filling this form in a full and complete manner.

[2] "New licensing regulation/procedure" is understood to refer to any newly introduced law, regulation or procedure, and those which are in force but being notified for the first time to the Committee.